title: Early abortion in Ontario: options and costs.
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: J J
authors.initials: JJ
authors.lastname: Limacher
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: I
authors.initials: I
authors.lastname: Daniel
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: S
authors.initials: S
authors.lastname: Isaacksz
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: G J
authors.initials: GJ
authors.lastname: Payne
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: S
authors.initials: S
authors.lastname: Dunn
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: P C
authors.initials: PC
authors.lastname: Coyte
authors.affiliation: Department of Health Policy, Management and Evaluation, University of Toronto, Toronto ON; Department of Family and Community Medicine, University of Toronto, Toronto ON.
authors.forename: A
authors.initials: A
authors.lastname: Laporte
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000191:economics* / Q000379:methods*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005865:Gestational Age; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use; D016595:Misoprostol / Q000627:therapeutic use; D009864:Ontario; D011247:Pregnancy; D016896:Treatment Outcome
chemical_list: D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone